Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "haves"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Search alternatives
:
"haves" »
"havens"
,
"waves"
,
"haven"
Showing
1
-
20
of
37
Search:
'"haves"'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... as well, including the eyes, lungs, heart, or skin. It is estimated that about 1% of Canadians
have
...
”
Read Now
2
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... as well, including the eyes, lungs, heart, or skin. It is estimated that about 1% of Canadians
have
...
”
Read Now
3
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... drugs (DMARDs) who
have
had inadequate response or intolerance to methotrexate. 2. Upadacitinib should...
”
Read Now
4
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... drugs (DMARDs) who
have
had inadequate response or intolerance to methotrexate. 2. Upadacitinib should...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...
Published 2020
CADTH
“
...) be reimbursed for the treatment of iron deficiency anemia (IDA) in adult patients who
have
intolerance...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...
Published 2020
CADTH
“
...) be reimbursed for the treatment of iron deficiency anemia (IDA) in adult patients who
have
intolerance...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... for the treatment of adult patients with active PsA who
have
responded inadequately to, or are intolerant to one...
”
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... for the treatment of adult patients with active PsA who
have
responded inadequately to, or are intolerant to one...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... in combination with MTX for the treatment of adult patients with moderate to severe RA who
have
responded...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... in combination with MTX for the treatment of adult patients with moderate to severe RA who
have
responded...
”
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
... (HCV) infection, without cirrhosis or with compensated cirrhosis, who
have
: genotype 1, 2, 3, 4, 5...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...) in patients who
have
been previously treated with a course of corticosteroids and did not
have
a clinically...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
... (HCV) infection, without cirrhosis or with compensated cirrhosis, who
have
: genotype 1, 2, 3, 4, 5...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Fluocinolone acetonide (Iluvien -- Knight Therapeutics Inc.) : indication : diabetic macular edema
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...) in patients who
have
been previously treated with a course of corticosteroids and did not
have
a clinically...
”
Read Now
15
CADTH Canadian drug expert committee recommendation: Ustekinumab (Stelara/Stelara I.V. -- Janssen Inc.) : indication : for the treatment of adult patients with moderately to severe...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... with moderately to severely active UC who
have
had an inadequate response with, lost response to, orwere...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Icosapent ethyl (Vascepa -- HLS Therapeutics Inc.) : indication : prevention of cardiovascular events in statin-treated patient...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...
have
a fasting TG of 1.7 mmol/L or greater and lower than 5.6 mmol/L at baseline, measured within...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
“
... for the treatment of adult patients with active ankylosing spondylitis who
have
responded inadequately...
”
Read Now
18
CADTH Canadian Drug Expert Review Committee final recommendation: Adalimumab (Humira -- abbVie) : indication: ulcerative colitis
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
have
had an inadequate response to conventional therapy including corticosteroids, azathioprine...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
“
... for the treatment of adult patients with active ankylosing spondylitis who
have
responded inadequately...
”
Read Now
20
CADTH Canadian drug expert committee recommendation: Erenumab (Aimovig -- Novartis pharmaceuticals Canada Inc.) : indication: prevention of migraine
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Erenumab has a Health Canada indication for the prevention of migraines in patients who
have
...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
35
330 - Economics
15
700 - The arts; fine & decorative arts
8
140 - Specific philosophical schools
2
Language
English
37
Collection
National Center for Biotechnology Information
37
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
33
Recently Uploaded
Last Month
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22haves%22&type=AllFields
Send by Email
×
Loading...